Arm versus leg access for clot removal in basilar stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares doing a clot-removal procedure through the arm artery versus the leg artery for an emergency stroke caused by a blocked basilar artery. It aims to see which access route is safer and more effective for restoring blood flow when time is critical.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older with an emergency stroke in the back of the brain (posterior circulation).
- Scans show a blockage in the basilar artery.
- You can be randomized within 24 hours of when symptoms started (and the team estimates the basilar blockage timing).
- Your stroke severity is moderate to severe (NIHSS score 10 or higher).
- You can have the procedure done through either the arm or leg, including a hand circulation test called the modified Allen’s test.
- You (or your legal representative) can sign consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a minimally invasive procedure to remove a large blood clot from the main artery at the back of the brain can help people who have had a severe stroke. It aims to improve recovery and reduce disability.
This trial tests a simple procedure that may help your brain recover after a stroke. The procedure involves briefly stopping and restarting blood flow in your arm, which may reduce brain damage and improve recovery after the clot removal.
This trial compares two ways of removing a blood clot from a large artery in the brain during an ischemic stroke. It might help you by finding out which method restores blood flow more safely and effectively.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial tests if a clot-busting drug called Tenecteplase helps people with a severe type of stroke in the back of the brain (basilar artery occlusion) when given 4.5 to 24 hours after symptoms start. Patients will then be moved to a hospital that can remove the clot. The goal is to see if the drug improves recovery.
This trial tests a procedure to remove a blood clot from the main artery at the back of the brain (basilar artery) in people who have a large stroke. The goal is to see if this treatment can improve recovery even when the stroke damage is bigger than usual.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.